| Q55232142 | "Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer. |
| Q39273026 | A Cost-Utility Analysis of Prostate Cancer Screening in Australia. |
| Q64069330 | A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor |
| Q38705859 | A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer |
| Q46167678 | A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel |
| Q42907440 | Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance |
| Q39391979 | Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer |
| Q37029385 | Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools |
| Q42736743 | Analysis of different tumor volume thresholds of insignificant prostate cancer and their implications for active surveillance patient selection and monitoring. |
| Q38657325 | Anatomic and Molecular Imaging in Prostate Cancer |
| Q39177286 | Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology |
| Q30843143 | Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer |
| Q40349425 | Assessment of prostate cancer aggressiveness using apparent diffusion coefficient values: impact of patient race and age. |
| Q57317473 | Clinical Implications of a Multiparametric Magnetic Resonance Imaging Based Nomogram Applied to Prostate Cancer Active Surveillance |
| Q47681129 | Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2. |
| Q40338554 | Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population |
| Q97559360 | Combined MRI-targeted plus systematic confirmatory biopsy improves risk stratification for patients enrolling on active surveillance for prostate cancer |
| Q30664726 | Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. |
| Q35852107 | Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies |
| Q58759334 | Comparisons between magnetic resonance/ultrasound fusion-guided biopsy and standard biopsy in the diagnosis of prostate cancer: A prospective cohort study |
| Q38716270 | Detection and grading of prostate cancer using temporal enhanced ultrasound: combining deep neural networks and tissue mimicking simulations |
| Q31072087 | Detection of prostate cancer using temporal sequences of ultrasound data: a large clinical feasibility study. |
| Q33783620 | Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers |
| Q38180533 | Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. |
| Q53084425 | Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI. |
| Q52887561 | Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations. |
| Q40751928 | Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance |
| Q50112903 | Future Perspectives and Challenges of Prostate MR Imaging |
| Q36386904 | Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. |
| Q38321182 | Imaging biomarkers in prostate cancer: role of PET/CT and MRI. |
| Q64936950 | Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond. |
| Q91640783 | Impact of PI-RADS v2 on indication of prostate biopsy |
| Q36108460 | Impact of an Information Technology-Enabled Initiative on the Quality of Prostate Multiparametric MRI Reports |
| Q47163242 | Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer. |
| Q30249514 | Integration of multiparametric MRI into active surveillance of prostate cancer. |
| Q34084254 | Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer |
| Q26744802 | Limitations and Prospects for Diffusion-Weighted MRI of the Prostate |
| Q90044063 | MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis |
| Q54967757 | Magnetic resonance imaging in active surveillance-a modern approach. |
| Q45967722 | Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. |
| Q44776478 | Multi-parametric (mp) MRI of prostatic ductal adenocarcinoma. |
| Q62050250 | Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer |
| Q64993061 | Multiparametric MRI - local staging of prostate cancer and beyond. |
| Q38294503 | Multiparametric MRI for localized prostate cancer: lesion detection and staging |
| Q34177428 | Multiparametric MRI in the PSA screening era |
| Q39390258 | Multiparametric MRI of the breast: A review |
| Q38786175 | Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems. |
| Q37377731 | Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline |
| Q26801576 | Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists |
| Q33911317 | Multiparametric magnetic resonance imaging of the prostate aids detect lesion progression |
| Q48307762 | Multiparametric magnetic resonance imaging of the prostate with computer-aided detection: experienced observer performance study. |
| Q51004664 | Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. |
| Q28081873 | Multiparametric-MRI in diagnosis of prostate cancer |
| Q35720507 | Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up |
| Q30882787 | Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension |
| Q52981879 | Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. |
| Q34475350 | Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment |
| Q38558548 | PI-RADS version 2: what you need to know |
| Q39108592 | PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER. |
| Q46567823 | Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation |
| Q40458086 | Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging. |
| Q53799750 | Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer. |
| Q35670525 | Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging |
| Q26739725 | Prostate MRI - an update for the referring urologist |
| Q38796980 | Prostate cancer risk stratification with magnetic resonance imaging |
| Q41177087 | Prostate cancer-specific mortality after radical prostatectomy: value of preoperative MRI. |
| Q43512791 | Prostate cancer: multiparametric MRI scans could be a useful adjunct for active surveillance in prostate cancer |
| Q57101049 | Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI) |
| Q38904161 | Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients. |
| Q55114396 | Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancer. |
| Q48342579 | Repeat multiparametric MRI in prostate cancer patients on active surveillance |
| Q31131775 | Review of Prostate Imaging Reporting and Data System version 2. |
| Q35680101 | Risk stratification of prostate cancer in the modern era. |
| Q38843182 | Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers |
| Q41821490 | Role for (11)C-choline PET in active surveillance of prostate cancer |
| Q39247844 | Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS. |
| Q39271404 | Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer |
| Q38671172 | Role of prostate magnetic resonance imaging in active surveillance. |
| Q38392814 | Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance. |
| Q38193586 | Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE"). |
| Q48527660 | Targeted Prostate Biopsy in the Era of Active Surveillance |
| Q34032598 | Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? |
| Q27027567 | Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer |
| Q57305669 | The Role of Image Guided Biopsy Targeting in Patients with Atypical Small Acinar Proliferation |
| Q40686963 | The changing role of imaging in clinical care |
| Q87790292 | The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer |
| Q34864876 | The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance |
| Q38504909 | The role of MRI in active surveillance for prostate cancer |
| Q34705261 | The role of MRI in prostate cancer active surveillance. |
| Q63966206 | The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer |
| Q93081310 | The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis |
| Q37580674 | The role of magnetic resonance imaging in delineating clinically significant prostate cancer |
| Q38746242 | The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men. |
| Q38722927 | Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique. |
| Q38795731 | Use of mpMRI in active surveillance for localized prostate cancer |
| Q53589252 | Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. |
| Q40114843 | Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer |
| Q47616425 | Validation of Prostate Imaging-Reporting and Data System Version 2: A Retrospective Analysis. |
| Q39513641 | Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance |